Liver regenerative medicine: advances and challenges

Area of Science:

• Regenerative Medicine
• Hepatology
• Biotechnology

Background:

• Liver transplantation is the standard treatment for end-stage liver disease, but donor organ scarcity poses a significant challenge.
• Liver failure leads to mortality before transplantation can occur.
• Liver regenerative medicine aims to develop novel therapies for organ repair and replacement.

Purpose of the Study:

• To review recent advancements in hepatic regenerative medicine over the past decade.
• To explore the potential of stem cells and tissue engineering in treating liver diseases.
• To discuss current challenges and future prospects in the field.

Main Methods:

• Characterization of liver organogenesis and stem/progenitor cells (fetal and adult).
• Review of cell therapy applications using primary hepatocytes and various stem cell types (embryonic, mesenchymal, hematopoietic, induced pluripotent).
• Analysis of hepatic tissue engineering strategies, including biomaterials, 3D scaffolds, microengineering, and bioartificial liver development.

Main Results:

• Significant progress has been made in understanding liver stem cells and their therapeutic applications.
• Advances in generating mature hepatocytes from stem/progenitor cells are being achieved.
• Development of 3D bioactive matrices, liver microengineering, and bioartificial livers shows promise.

Conclusions:

• Hepatic regenerative medicine, encompassing cell therapy and tissue engineering, presents a promising alternative to liver transplantation.
• Continued research into stem cell differentiation and biomaterial development is crucial for clinical translation.
• The fabrication of bioengineered livers holds potential for future liver regeneration therapies.